학술논문

Early beginning of alemtuzumab: Changing the multiple sclerosis treatment paradigm. Interim analysis of the LEMVIDA study
Document Type
Article
Source
In Neurología (English Edition) June 2024 39(5):383-391
Subject
Language
ISSN
2173-5808